Seminars For Health Technology  

Is there lobbying pressure on the work of the industry?

At times it may feel interest and it is inevitable. It is not only at home, but anywhere in the EU, where such decisions are taken that affect financially, especially in times of economic crisis.

Seminars for health technology assessment recently presented data on a significant reduction in the prices of some medicines reimbursed by the NHIF.

http://en.wikipedia.org/wiki/Medicine

Please analyze this briefly your experience - how did the idea to undergo quarterly monitoring therapy with these 25 substances paid by NHIF 100% and what conclusions did you come?

Indeed, it is very important to take into account the work that we do and to show that the benefits of such a structure.

Since last 10 years, none of the previous committee has not been analyzed and reports are scarce or do not exist, we decided that we should embark on any basis.

Moreover, regular checks in the reference countries were not fact. Since the Council is an independent body, these processes are listed and classified.

Although by law was required to carry out checks of 12 months, this is not carried out by previous commissions when this activity was divided. Obviously, there was no administrative capacity and control of these processes to be carried out.

http://www.fatlossfactoreviewscam.com/flf-weight-tracker/

And another related question - Is this relevant experience in relation to medical devices - most recently in the media information drastic discrepancies between the prices at which these products are imported here and the prices at which they purchase the patients?

It is quite complicated to apply the same approach to medical devices, as with drugs. Under European legislation on medical devices there is no price regulation. In this connection, reference pricing is not applicable.